{"nct_id":"NCT01299480","title":"A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2011-03-03","start_date_type":"ACTUAL","primary_completion_date":"2012-05-03","primary_completion_date_type":"ACTUAL","completion_date":"2012-09-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}